Find a Tender
planned
Official procurement procedure
Cell selection system for the preparation of purified stem cells
Diagnostic devices
Diagnostic supplies
Diagnostic systems
+1 more
Published value
£6,000,000
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: NHS Blood and Transplant: "Cell selection system for the preparation of purified stem cells". Published status: planned. Published value: £6,000,000. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
| Contracting Authority | NHS Blood and Transplant | Scope & Categories | Not published | Submission Window | planned No deadline published |
|---|---|---|---|---|---|
| Submission Gateway | Direct notice route | Legal Basis & Regime | Standard procurement | Estimated Value (exc. VAT) | £6,000,000 |
Bidder Intelligence · Authority Profile: NHS Blood and Transplant
Market Analytics
Derived from OCDS awards & bid statistics
Published history for NHS Blood and Transplant. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Competition Density
2Bids / Report
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate availablePayment Terms
Check noticePublished terms
Coverage: 15 active published awards; 13 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityNHS Blood and Transplant | Procedure methodNot published | Procurement categoryNot published |
Statusplanned | Framework / DPSNot published | CompetitionNot published |
Above thresholdNot published | Legal basisNot published | Tender period startsNot published |
Clarification deadlineNot published | Electronic submissionNot published | Submission languagesNot published |
Published5 Jul 2024, 16:47 BST | Last source update5 Jul 2024, 16:47 BST | Recurring procurementNot published |
ClassificationDiagnostic devices, Diagnostic supplies, Diagnostic systems, Laboratory reagents | ||
Delivery area | ||
OCIDocds-h6vhtk-047b4c | ||
What is being bought
This Prior Information Notice (PIN) is separate to any tender opportunity.<br/>The Cellular & Molecular Therapies (CMT) laboratories within NHS Blood and Transplant ( NHSBT) provide a range of services to support haemopoietic stem cell transplantation including collection, processing, and cryopreservation of stem cells. An important part of the services offered by CMT is the purification of stem cells and depletion of other cells, such as CD3+, TCRαβ, CD19+ cells, that may cause complications in the transplant procedures.<br/>The purpose of this notice is to:<br/>• Alert potential suppliers that NHSBT intends to award a contract for the supply of consumables and maintenance of existing equipment and in addition potential purchase of new equipment & maintenance in the future if demand increases.<br/>• Develop NHSBTs understanding of the capabilities, dependencies and competitiveness of the marketplace and the ability of industry to provide the required level of support.<br/>Please express your interest by the 29th of July and direct any questions to tennille.madigan@nhsbt.nhs.uk
What changed
From the official release history
- Published value updated to £6,000,000
5 Jul 2024, 16:47 BST - Status changed to planned
5 Jul 2024, 16:47 BST - Official notice release published
5 Jul 2024, 16:47 BST - Buyer information updated
5 Jul 2024, 16:47 BST
Lots and requirements (1)
Published by the contracting authority
- Lot 1 · #1Individual lot title not publishedplannedPublished valueNot publishedThis Prior Information Notice (PIN) is separate to any tender opportunity.<br/>The Cellular & Molecular Therapies (CMT) laboratories within NHS Blood and Transplant ( NHSBT) provide a range of services to support haemopoietic stem cell transplantation including collection, processing, and cryopreservation of stem cells. An important part of the services offered by CMT is the purification of stem cells and depletion of other cells, such as CD3+, TCRαβ, CD19+ cells, that may cause complications in the transplant procedures.<br/>The purpose of this notice is to:<br/>• Alert potential suppliers that NHSBT intends to award a contract for the supply of consumables and maintenance of existing equipment and in addition potential purchase of new equipment & maintenance in the future if demand increases.<br/>• Develop NHSBTs understanding of the capabilities, dependencies and competitiveness of the marketplace and the ability of industry to provide the required level of support.<br/>Please express your interest by the 29th of July and direct any questions to tennille.madigan@nhsbt.nhs.ukContract periodNot publishedEligibilityNot publishedOptions / renewalNot published
Timeline
- Procedure published
5 Jul 2024, 16:47 BST
Commercial outcome and competition
AwardsNo award published |
ContractsNo contract published |
Bid statisticsNo aggregate bid statistics published |
Buyer and organisations in this procedure
NHS Blood and Transplant
Contracting authority GB-FTS-13217Documents (0)
Official links; attachments are not copied
No linked documents are published
Related procedures (0)
No related procedures published